Phibro Animal Health Corporation Class A Common Stock (PAHC)
Stock · NASDAQ · Health Care
$37.64as of 8/28/2026
Price chart
Open in TradingViewActive signals
Support level
$31.54
Industry
Biotechnology: Pharmaceutical Preparations
About PAHC
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Website
- www.pahc.com/
Fundamentals
- Market cap
- $1.44B
- P/E (trailing)
- 14.51
- P/E (forward)
- —
- EPS (trailing)
- $2.33
- Dividend yield
- 4.55%
- Beta
- 0.42
- Avg. volume
- —
52-week range
$28.25$60.08
How Phibro Animal Health Corporation Class A Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Aug 27, 2025 · via SEC EDGAR / Finnhub
Phibro Animal Health Corporation Class A Common Stock Competitors
Chosen by industry and closest market cap.
- PAHCPhibro Animal Health Corporation Class A Common Stock$37.64▲ 3.55%Market cap $1.44BP/E 14.51$28.25$60.08
- AVBPArriVent BioPharma Inc. Common Stock$30.19▼ 2.63%Market cap $1.44BP/E —$17$35.83
- AVLNAvalyn Pharma Inc. Common Stock$34.67▼ 5.04%Market cap $1.45BP/E —$24.15$40.17
- HROWHarrow Inc. Common Stock$37.23▼ 3.40%Market cap $1.49BP/E —$28.54$54.85
- LBRXLB Pharmaceuticals Inc Common Stock$47.8▼ 0.20%Market cap $1.38BP/E —$13.36$50.16
- SDGRSchrodinger Inc. Common Stock$19.7▼ 3.48%Market cap $1.33BP/E —$10.95$23.02
- INVAInnoviva Inc. Common Stock$20.97▲ 0.05%Market cap $1.56BP/E 4.21$16.52$25.15
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| PAHC Phibro Animal Health Corporation Class A Common Stock | $1.44B | 14.51 | $37.64 | ▲ 3.55% | $28.25$60.08 |
| AVBP ArriVent BioPharma Inc. Common Stock | $1.44B | — | $30.19 | ▼ 2.63% | $17$35.83 |
| AVLN Avalyn Pharma Inc. Common Stock | $1.45B | — | $34.67 | ▼ 5.04% | $24.15$40.17 |
| HROW Harrow Inc. Common Stock | $1.49B | — | $37.23 | ▼ 3.40% | $28.54$54.85 |
| LBRX LB Pharmaceuticals Inc Common Stock | $1.38B | — | $47.8 | ▼ 0.20% | $13.36$50.16 |
| SDGR Schrodinger Inc. Common Stock | $1.33B | — | $19.7 | ▼ 3.48% | $10.95$23.02 |
| INVA Innoviva Inc. Common Stock | $1.56B | 4.21 | $20.97 | ▲ 0.05% | $16.52$25.15 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Phibro Animal Health Q4 2026 Earnings Call: Complete Transcriptbenzinga · 8/27/2026
- Zoetis: A Solid Long-Term Buy After Harsh DrawdownSeekingAlpha · 8/18/2026
Insider Activity
Insider Actions →Acquired
338.9K
Disposed
5.0K
- Rodriguez Patrick · August 6, 2026 · Grant1.5K
- David Glenn · August 6, 2026 · Grant3.3K
- Miller Larry Lee · August 6, 2026 · Grant3.5K
- BENDHEIM Jonathan · August 6, 2026 · Grant2.7K
- Weinstein Judith · August 6, 2026 · Grant2.5K
- BENDHEIM JACK · August 6, 2026 · Grant12.1K
- Escudero Lisa Ann · August 6, 2026 · Grant1.5K
- Bendheim Daniel M · August 6, 2026 · Grant11.7K
- BENDHEIM JACK · August 4, 2026 · J2.3K @ $36.6
- Escudero Lisa Ann · August 4, 2026 · J265 @ $36.6
- Miller Larry Lee · August 4, 2026 · J635 @ $36.6
- Weinstein Judith · August 4, 2026 · J472 @ $36.6
- David Glenn · August 4, 2026 · J840 @ $36.6
- Bendheim Daniel M · August 4, 2026 · J486 @ $36.6
- Bendheim Daniel M · July 1, 2026 · Grant300.0K
Institutional Ownership
March 31, 2026
- Total shares held
- 19.46M
- Total value held
- $995.09M
- Institutional holders
- 251
Top holders this quarter
- Unknown3.25M
- Unknown2.17M
- Unknown950.0K
- Unknown891.3K
- Unknown617.1K
- Unknown604.6K
- Unknown576.7K
- Unknown507.9K
- Unknown455.9K
- Unknown397.7K
See the full, filterable feed with live charts on the MarketWall dashboard.